According to a new report by Polaris Market Research, the U.S. immunoassay market was valued at USD 11.72 billion in 2024 and is projected to reach USD 18.49 billion by 2034, expanding at a CAGR of 4.6% over the forecast period. Growth is underpinned by a rapidly aging population, rising rates of chronic and infectious disease, and accelerating automation and multiplex-testing...